ACUVUE™ RevitaLens

Multi-Purpose Disinfecting Solution
The right contact lens solution can make a difference in your patients' lens wear experience1-3

ACUVUETM RevitaLens MPDS disinfects like a peroxide with the simplicity and all-day comfort of an advanced multi-purpose solution.4-6

With ACUVUETM RevitaLens MPDS, you can be assured that your patients experience exceptional disinfection and all-day comfort.2,4-7

ACUVUETM RevitaLens MPDS is a sterile, buffered aqueous solution with Alexidine 0.00016%, Polyquaternium-1 0.0003%, Boric acid, Sodium borate decahydrate, TETRONIC 904, Edetate disodium (EDTA), Trisodium citrate dihydrate, Sodium chloride and Purified water.

acuvue revitalens

Sizes Available:

100 ml

300 ml

Benefits

Protection for your Patients

ACUVUETM RevitaLens MPDS provides sustained lens disinfection in the lens case—even after partial evaporation.#10  It is gentle on the eye and delivers exceptional disinfection against harmful germs and bacteria.11,12

Comfort for your Patients

ACUVUETM RevitaLens MPDS delivers the all-day comfort your patients need.2,7,8

  •  90% of patients agree that ACUVUETM RevitaLens MPDS was effective in keeping their  contact lenses feeling comfortable.±13
  •  Nearly 94% of patients found ACUVUETM RevitaLens MPDS effective in keeping their contact lenses feeling clean.±13

A tried and tested combination you and your patients can rely ​on1-3

Offering a compatible lens solution is an important part of caring for your contact lens patients.1-3 In clinical studies, the combination of ACUVUETM RevitaLens MPDS and ACUVUE® Brand Contact Lenses resulted in:

  • All-day comfort2,7,8
  • Healthy ocular surface physiology13

ACUVUETM RevitaLens MPDS cleans, rinses, disinfects, stores, removes surface deposits including lipids and proteins, and re-wets soft (hydrophilic) contact lenses.

# 6 multi-purpose solutions tested in study. Results present for solutions that are still commercially available.
± Multicenter, open-label study in Europe and USA (n=2,979)
1. JJV Data on File 2017. RevitaLens OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2 week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory evaluations with ACUVUE® Brand reusable contact lens materials).
2. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric contact lenses with RevitaLens OcuTec MPDS, worn for 30 days, n=130 habitual soft toric contact lens wearers in US.
3. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
4. Heaselgrave W, Kilvington S, Lonnen J. Efficacy of contact lens care solutions against clinical microorganisms [Abstract 56]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK, 2011,34(1):S30.
5. Nikolic M, Kilvington S, Brady N, et al. Comparative efficacy of new contact lens care solutions against bacteria, fungi and Acanthamoeba [abstract 59]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK., 2011,34(1):S31.
6. Kilvington S, Huang L, Kao E, et al. Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance. J Optom 2010;3(3):134-142.
7. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective comfort and physiology with modern contact lens care products. Optom Vis Sci. 2016;93(8):809-819.
8. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS. n=95 habitual soft toric contact lens wearers in the US.
9. JJV Data on File 2018. Blink RevitaLens MPDS Compatibility and Clinical Performance with Reusable ACUVUE® Brand Contact Lenses.
10. Kilvington S, Powell CH, Lam A, et al. Antimicrobial efficacy of multi-purpose contact lens disinfectant solutions following evaporation. Contact Lens Anterior Eye. 2011;34(4):183-187.
11. Tarantino N, Kao E, Huang L, et al. A clinical safety and acceptability evaluation of a novel multi-purpose disinfecting solution [abstract 60]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010. Contact Lens Anterior Eye. 2010;33(6):256-300. doi: 10.1016/j.clae.2010.07.002.
12. Tilia D, Lazon de la Jara P, Weng R, et al. Clinical evaluation of a new contact lens solution when used in conjunction with two silicone hydrogel lenses during short term wear [abstract 31]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010.Contact Lens Anterior Eye. 2010;33(6):256-300. doi:10.1016/j.clae.2010.07.002.
13. Owen JP. Global RevitaLens Experience and Acceptance Trial (GREAT Trial) [abstract 4720]. In: Association for Research in Vision and Ophthalmology. Invest. Ophthalmol. Vis. Sci. 2012;53(14):13-6954.

 

Important Safety Information: ACUVUE™ Revitalens Multi-Purpose Disinfecting Solution (MPDS) is indicated for the care of soft (hydrophilic) contact lenses, including silicone hydrogel lenses. For detailed product information, including warnings and precautions, please consult the Instructions for Use. Failure to do so may result in serious eye infection or injury.

2024PP16281

Benefits

ACUVUETM RevitaLens MPDS delivers:

  • Broad-spectrum disinfection against FDA/ISO standard-panel microorganisms, comparable to peroxide systems4-6
  • Greater than 99.9% kill-rate against both forms of Acanthamoeba (in vitro)5,6
  • Lens comfort that lasts all day2,7-8
  • A great match with leading contact lenses, including ACUVUE® Brand Contact Lenses9
  • Recommend ACUVUETM RevitaLens MPDS to your reusable soft (hydrophilic) contact lens wearers with confidence - especially to those who use ACUVUE® Brand contact lenses1-3

1. JJV Data on File 2017. RevitaLens OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2 week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory evaluations with ACUVUE® Brand reusable contact lens materials).
2. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric contact lenses with RevitaLens OcuTec MPDS, worn for 30 days, n=130 habitual soft toric contact lens wearers in US.
3. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
4. Heaselgrave W, Kilvington S, Lonnen J. Efficacy of contact lens care solutions against clinical microorganisms [Abstract 56]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK, 2011,34(1):S30.
5. Nikolic M, Kilvington S, Brady N, et al. Comparative efficacy of new contact lens care solutions against bacteria, fungi and Acanthamoeba [abstract 59]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK., 2011,34(1):S31.
6. Kilvington S, Huang L, Kao E, et al. Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance. J Optom 2010;3(3):134-142.
7. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective comfort and physiology with modern contact lens care products. Optom Vis Sci. 2016;93(8):809-819.
8. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS. n=95 habitual soft toric contact lens wearers in the US.
9. JJV Data on File 2018. Blink RevitaLens MPDS Compatibility and Clinical Performance with Reusable ACUVUE® Brand Contact Lenses.

 

Important Safety Information: ACUVUE™ Revitalens Multi-Purpose Disinfecting Solution (MPDS) is indicated for the care of soft (hydrophilic) contact lenses, including silicone hydrogel lenses. For detailed product information, including warnings and precautions, please consult the Instructions for Use. Failure to do so may result in serious eye infection or injury.

2024PP16281